Swaroop S. Sonone | Medicine and Health Sciences | Best Faculty Award

Published on by Forensic Scientist

Mr. Swaroop S. Sonone | Medicine and Health Sciences | Best Faculty Award

School of Forensic Sciences, JSPM University, Pune | India

Mr. Swaroop S. Sonone, Assistant Professor at the School of Behavioural and Forensic Sciences, Jayawant Shikshan Prasarak Mandal (JSPM) University, Pune, India, is a distinguished academic and researcher specializing in Digital and Cyber Forensics, Forensic Ballistics, and Cyber Psychology. He holds an M.Sc. in Forensic Science (Digital & Cyber Forensics) and a B.Sc. in Forensic Science from Dr. Babasaheb Ambedkar Marathwada University, Aurangabad, along with a Diploma in Photography. He has qualified multiple national eligibility tests, including UGC-NET (three times) and MH-SET (SPPU, 2021), showcasing his academic competence and commitment to higher education. His research credentials, as indexed in Scopus (Author ID: 57219960845; ORCID: 0000-0002-3358-348X), include 24 publications, 670 citations, and an h-index of 5, reflecting his consistent scholarly contribution and scientific impact. Mr. Sonone has demonstrated exemplary academic leadership as Programme Coordinator, IQAC Coordinator, and Editor of the International Journal of Forensic Sciences (IJFSC). His notable publications, such as Water Contamination by Heavy Metals (2020) and Unveiling the Power of Nanoparticles for Latent Fingerprints (2024), highlight his interdisciplinary expertise bridging forensic and environmental sciences. Recognized for his excellence in teaching and research, he received the Young Forensic Faculty Award (NAEF-2025) by ThinkSakshya. Beyond academia, he actively engages in public science communication through national media, fostering forensic awareness. With his intellectual rigor, innovation, and leadership, Mr. Swaroop S. Sonone continues to advance forensic science education and research in India, exemplifying professional excellence and academic integrity.

Profile: Scopus | ORCID | Google Scholar | ResearchGate | LinkedIn | Staff Page

Featured Publications

  • Sonone, S. S., Jadhav, S., Sankhla, M. S., & Kumar, R. (2020). Water contamination by heavy metals and their toxic effect on aquaculture and human health through food chain. Letters in Applied NanoBioScience, 10(2), 2148–2166. Cited by 562.

  • Gulia, S., Rohilla, R. K., Sankhla, M. S., Kumar, R., & Sonone, S. S. (2020). Impact of pesticide toxicity in aquatic environment. Biointerface Research in Applied Chemistry, 11(3), 10131–10140. Cited by 166.

  • Verma, R. K., Sankhla, M. S., Rathod, N. V., Sonone, S. S., Parihar, K., & Singh, G. K. (2022). Eradication of fatal textile industrial dyes by wastewater treatment. Biointerface Research in Applied Chemistry, 12(1), 567–587. Cited by 74.

  • Mohan, H., Rajput, S. S., Jadhav, E. B., Sankhla, M. S., Sonone, S. S., Jadhav, S., et al. (2021). Ecotoxicity, occurrence, and removal of pharmaceuticals and illicit drugs from aquatic systems. Biointerface Research in Applied Chemistry, 11(5), 12530–12546. Cited by 65.

  • Singhal, M., Jadhav, S., Sonone, S. S., Sankhla, M. S., & Kumar, R. (2021). Microalgae-based sustainable bioremediation of water contaminated by pesticides. Biointerface Research in Applied Chemistry, 12, 149–169. Cited by 54.

Xuan Zhang | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Assist. Prof. Dr. Xuan Zhang | Medicine and Health Sciences | Best Researcher Award

Hong Kong Baptist University | Hong Kong

Dr. Xuan Zhang is a highly respected Lecturer II at the School of Chinese Medicine, Hong Kong Baptist University. As a registered Chinese Medicine Practitioner in both Mainland China and Hong Kong, she has cultivated a strong academic and clinical foundation rooted in traditional Chinese medicine principles. Since joining HKBU in 2016, she has significantly contributed to teaching, research, and international academic collaborations. Her leadership in evidence-based research, combined with her deep understanding of the Huangdi Neijing and classical theories such as the Five Circuits and Six Qi, positions her as a pioneer in integrating tradition with modern scientific approaches. Dr. Zhang has led or participated in more than 15 externally funded projects and published over 100 peer-reviewed articles, with a strong record of first- and corresponding-author contributions.

Professional Profile

ORCID

Scopus

Education

Dr. Zhang earned her Ph.D. in Chinese Medicine from the prestigious Beijing University of Chinese Medicine. Her doctoral training provided a rich combination of theoretical studies, classical text interpretation, and hands-on clinical applications. The academic environment fostered her early interest in integrating traditional Chinese medical theories with scientific methodologies. Her educational path laid the groundwork for her to pursue rigorous research in both the theoretical foundations and practical applications of Chinese medicine, particularly in the fields of epidemiology, gastrointestinal diseases, and methodological development.

Experience

With close to a decade of academic and clinical teaching experience, Dr. Zhang has taken on numerous roles that extend beyond the classroom. Since joining HKBU in 2016, she has secured seven research grants as Principal Investigator and served as co-investigator in multiple national-level projects funded by organizations such as the National Natural Science Foundation of China and the Chinese Medicine Development Fund (HKSAR). Her expertise has led to contributions in reporting guideline development, multicentre clinical trials, and telemedicine studies. She also serves on editorial boards for international journals such as Scientific Reports, BMC Medical Research Methodology, and the Journal of Traditional Chinese Medical Sciences, underscoring her standing in the academic community.

Research Interests

Dr. Zhang’s core research areas include: (1) theoretical and clinical research based on the Huangdi Neijing, with a focus on the “Five Circuits and Six Qi” (Wu Yun Liu Qi); (2) development of evidence-based Chinese medicine practices and methodological reporting standards; (3) clinical studies on gastrointestinal diseases such as IBS and ulcerative colitis; and (4) epidemiological research in infectious diseases within the framework of Chinese medicine. She has championed multidisciplinary and cross-regional collaborations that explore the integration of data science with ancient medical systems. Her ongoing work also addresses the modernization and standardization of traditional practices to ensure global acceptance and scientific validation.

Awards and Recognition

Dr. Zhang has received numerous awards for her outstanding research and contributions to Chinese medicine. She was named among China’s CNKI Highly Cited Scholars (Top 1%) and received the “Top Cited Article” award in the Journal of Evidence-Based Medicine. She was also honored as one of the “100 Outstanding Reviewers” of the China Journal of Traditional Chinese Medicine and Pharmacy and recognized as the “1st Qiu Zhen Scholars of Chinese Medicine.” Additionally, she earned the “Top Articles in Outstanding S&T Journals of China” award twice and the “Third Prize of Science and Technology Award” from the China Association of Chinese Medicine. These accolades reflect her significant impact on both theoretical and applied Chinese medicine research.

Publications

  1. Title: A Protocol for Developing, Disseminating, and Implementing a Core Outcome Set for Clinical Trials of Integrative Chinese and Western Medicine for Ulcerative Colitis
    Journal: Journal of Integrative Medicine
    Published on: 31 Jul 2025

  2. Title: Butyrate-producing commensal bacteria mediates the efficacy of herbal medicine JCM-16021 on abdominal pain in diarrhea-predominant irritable bowel syndrome: a randomized clinical trial
    Journal: Phytomedicine
    Published on: Sep 2025

  3. Title: Outcomes reporting in clinical trials of Chinese herbal medicine on ulcerative colitis: A systematic review
    Journal: Journal of Evidence-Based Medicine
    Published on: 28 Oct 2024

  4. Title: Suboptimal reporting of randomized controlled trials on non-pharmacological therapies in Chinese medicine
    Journal: Frontiers in Medicine
    Published on: 17 Jun 2024

  5. Title: Transparency and reporting characteristics of randomized controlled trials with Chinese herbal medicine formulas interventions
    Journal: Frontiers of Medicine
    Published on: 17 May 2024

  6. Title: STandards for Reporting Interventions in Clinical Trials Of Tuina/Massage (STRICTOTM): Extending the CONSORT Statement
    Journal: Journal of Evidence-Based Medicine
    Published on: 14 Mar 2023

  7. Title: Reporting assessment of multicenter clinical trial protocols: a cross-sectional study
    Journal: Journal of Evidence-Based Medicine
    Published on: 03 Mar 2023

Conclusion

Dr. Xuan Zhang is a distinguished researcher, educator, and clinical scholar whose work reflects a deep integration of traditional Chinese medicine principles with contemporary clinical and scientific practices. Her extensive publication record, grant leadership, and editorial responsibilities demonstrate her strong research acumen and commitment to globalizing Chinese medicine. With high-impact contributions, international collaborations, and multiple recognitions for academic excellence, Dr. Zhang is a highly deserving candidate for the Best Researcher Award. Her work continues to shape the future of evidence-based Chinese medicine and methodological innovation.

Ji Li | Medicine and Health Sciences | Best Scholar Award

Published on by Forensic Scientist

Prof. Ji Li | Medicine and Health Sciences | Best Scholar Award

Central South University | China

Professor Ji Li, PhD, is a distinguished scholar in dermatological sciences, currently serving in the Department of Dermatology at Xiangya Hospital, Central South University, China. Renowned for groundbreaking research in inflammatory dermatosis and skin aging, Professor Ji has significantly advanced clinical and molecular dermatology through over a decade of academic contributions.

Author Profile👤

Scopus

Strengths for the Awards✨

Professor Ji Li, PhD, has firmly established herself as a leading figure in dermatological research, particularly in the areas of inflammatory dermatosis and skin aging. Her academic contributions are highly impactful, with over 100 SCI-indexed publications in prestigious international journals, such as BMJ, Science Advances, Developmental Cell, EMBO Journal, JAAD, JAMA Dermatology, and Journal of Investigative Dermatology. This extensive publication record underscores her sustained productivity and global recognition.

In addition to scholarly output, her ability to attract six projects funded by the National Natural Science Foundation of China (NSFC) demonstrates her competence in leading significant, peer-reviewed scientific research with national and institutional importance. Her dual roles as first and corresponding author reflect intellectual leadership and mentorship capability, making her a strong candidate for the Best Scholar Award.

🎓 Education

Professor Ji Li earned a Ph.D. in Dermatology and has since cultivated a strong academic foundation that supports both clinical excellence and scientific innovation. Their academic journey is rooted in top-tier institutions, combining rigorous research training with a focus on translational skin biology.

🧪 Experience

With a long-standing tenure at Xiangya Hospital, Professor Ji Li has blended clinical dermatology practice with laboratory-based investigation, leading several research groups and mentoring young scientists. With active involvement in national and international dermatological communities, Ji Li is recognized as a clinical-scientific leader in the field.

🔬 Research Interest On Medicine and Health Sciences

Professor Ji’s core research areas include:

  • Inflammatory dermatoses, exploring molecular mechanisms and treatment strategies

  • Skin aging, investigating cellular aging pathways and potential rejuvenation therapies
    These interests are supported by a rich body of work that bridges clinical needs and molecular science.

🏆 Award

Professor Ji Li has been honored with several prestigious recognitions, including grants from the National Natural Science Foundation of China (with 6 funded projects), underlining the scientific community’s acknowledgment of Ji’s excellence and innovation. The consistent impact of Ji’s work positions them as a leading nominee for the Best Scholar Award.

📚 Publications

Professor Ji Li has authored over 100 SCI-indexed papers as first or corresponding author, published in top-tier international journals. Notable recent publications include:

💡 Conclusion

Professor Ji Li exemplifies the values of the Best Scholar Award through a rare combination of clinical expertise, scientific vision, and impactful scholarship. With extensive contributions to inflammatory skin diseases and aging, an outstanding publication record, and robust grant support, Ji stands out as a trailblazer in dermatology research. Their leadership continues to inspire innovation, mentorship, and global collaboration.

Marwa Refaie | Medicine and Health Sciences | Pioneer Researcher Award

Published on by Forensic Scientist

Assist. Prof. Dr. Marwa Refaie | Medicine and Health Sciences | Pioneer Researcher Award

Minya University | Egypt

Dr. Marwa Monier Mahmoud Refaie is an esteemed Egyptian pharmacologist and academician currently serving as an Assistant Professor in the Department of Pharmacology, Faculty of Medicine, Minia University. With an H-index of 18 on both Scopus and Google Scholar, she has made impactful contributions to pharmacological research, particularly in drug safety, toxicology, and disease treatment models. Born on July 2, 1983, in Mallawi, El-Minia, Dr. Refaie balances her thriving career with family life, being a proud mother of three sons.

Professional profile👤

Google Scholar

Scopus

ORCID

Strengths for the Awards✨

Dr. Marwa Monier Mahmoud Refaie demonstrates a remarkable profile that aligns seamlessly with the ethos of the Pioneer Researcher Award. With over 16 years of academic and research experience in pharmacology, she has established herself as a thought leader in experimental and clinical pharmacology, especially in toxicology, nephroprotection, cardioprotection, and hormonal therapy research.

Her impressive H-index of 18 (Scopus & Google Scholar) reflects the consistent impact of her work on the scientific community. Dr. Refaie has authored over 40 international publications, many in high-impact journals, and has investigated novel therapeutic mechanisms for critical conditions like nephrotoxicity, PCOS, and ischemia-reperfusion injuries. Her robust experimental skill set, prolific mentorship of postgraduate students, and service on editorial boards of globally recognized journals (e.g., British Journal of Pharmacology, Elsevier journals) reflect both leadership and innovation in her field. Moreover, her multiple awards from Minia University for international publication over consecutive years affirm her consistency and excellence in pioneering pharmacological research.

🎓 Education

Dr. Refaie began her academic journey at Minia University, earning her MBBS in Medicine and Surgery in 2006. She further specialized in pharmacology, completing her Master’s in 2011 and a Ph.D. in Basic and Clinical Pharmacology in 2016. Expanding her interdisciplinary expertise, she also earned a Diploma in Infection Control in 2021, highlighting her dedication to integrated healthcare education and safety.

🧪 Experience

With over 16 years of academic and research experience, Dr. Refaie has evolved from a Demonstrator to Assistant Professor at Minia University. Her work spans teaching basic and clinical pharmacology to medical, dental, pharmacy, and nursing students, and supervising numerous M.Sc. and Ph.D. theses. Her research explores pharmacotherapy, cancer, autoimmune diseases, and drug safety, and she has actively contributed to institutional accreditation, infection control, and community healthcare education.

🔬 Research Interests On Medicine and Health Sciences

Dr. Refaie’s research is driven by a passion for understanding and combating toxicological and precancerous conditions. Her focus lies in modeling and treating organ-specific toxicity, ischemia-reperfusion injuries, and hyperplastic lesions. Her work also explores novel mechanisms of cardioprotection, reproductive toxicity, and immunomodulation using pharmacological agents such as diacerein, fenofibrate, and SGLT2 inhibitors.

🏆 Awards

Dr. Refaie has received consistent recognition for her excellence in research and publication. She was awarded first place at the 57th Annual Conference of the Egyptian Society of Pharmacology and Experimental Therapeutics (2018). Additionally, she has received Minia University’s International Publication Award for six consecutive years (2019–2024), reflecting her sustained contributions to global pharmacological science.

📚 Publications

  • Effect of coenzyme‐Q10 on doxorubicin‐induced nephrotoxicity in rats
    AAK El-Sheikh, MA Morsy, MM Mahmoud, RA Rifaai, AM Abdelrahman
    2012 – Cited by: 147

  • Possible protective effect of diacerein on doxorubicin‐induced nephrotoxicity in rats
    MMM Refaie, EF Amin, NF El-Tahawy, AM Abdelrahman
    2016 – Cited by: 96

  • Mechanism mediating the protective effect of diacerein in ischemia-reperfusion-induced testicular injury in rats
    SA Abdel-Gaber, RK Mohammed, MMM Refaie
    2018 – Cited by: 62

  • Protective mechanisms of coenzyme-Q10 may involve up-regulation of testicular P-glycoprotein in doxorubicin-induced toxicity
    AAK El-Sheikh, MA Morsy, MM Mahmoud, RA Rifaai
    2014 – Cited by: 52

  • Naringenin palliates cisplatin and doxorubicin gonadal toxicity in male rats
    AA Fouad, MMM Refaie, MI Abdelghany
    2019 – Cited by: 50

  • The role of interleukin‐1β and its antagonist (diacerein) in estradiol benzoate‐induced endometrial hyperplasia and atypia in female rats
    MMM Refaie, M El‐Hussieny
    2017 – Cited by: 48

  • Role of ATP-Sensitive Potassium Channel (KATP) and eNOS in Mediating the Protective Effect of Nicorandil in Cyclophosphamide-Induced Cardiotoxicity
    MMM Refaie, S Shehata, M El-Hussieny, WM Abdelraheem, …
    2020 – Cited by: 46

  • Assessment of Antibacterial and Anti-biofilm Effects of Vitamin C Against Pseudomonas aeruginosa Clinical Isolates
    WM Abdelraheem, MMM Refaie, RKM Yousef, AS Abd El Fatah, …
    2022 – Cited by: 44

  • Protective role of nebivolol in cadmium-induced hepatotoxicity via downregulation of oxidative stress, apoptosis and inflammatory pathways
    MMM Refaie, M El-Hussieny, NM Zenhom
    2018 – Cited by: 43

  • Protective effect of pioglitazone on ovarian ischemia reperfusion injury of female rats via modulation of peroxisome proliferator activated receptor gamma and heme-oxygenase 1
    MMM Refaie, M El-Hussieny
    2018 – Cited by: 41

📝 Conclusion

🌟 Dr. Marwa M. Refaie exemplifies excellence in academic pharmacology through her sustained research, impactful publications, and commitment to medical education. Her work spans cutting-edge experimental pharmacology, disease modeling, and immunotherapy. Her consistent accolades, active international collaborations, and editorial contributions to top journals affirm her candidacy as a distinguished nominee for prestigious research awards. Her legacy in pharmacological sciences continues to inspire and uplift the global scientific community.

 

Qianghua Lv | Medicine | Best Researcher Award

Published on by Forensic Scientist

Prof. Dr. Qianghua Lv | Medicine | Best Researcher Award

Shandong Academy of Agricultural Sciences | China

Dr. Qianghua LV is an Associate Researcher at the Institute of Animal Science and Veterinary Medicine (IASVM), Shandong Academy of Agricultural Sciences (SAAS). He earned his Ph.D. in Veterinary Pharmacology under the mentorship of Prof. DENG Xuming at Jilin University in 2020. His research focuses on developing novel therapeutic strategies targeting bacterial virulence factors, including bacterial hemolysin, Type III Secretion System (T3SS), and Type IV Pili (TFP). His work contributes significantly to understanding anti-infective mechanisms and advancing new drug development against bacterial infections.

Profile👤

ORCID

Strengths for the Awards✨

  • High-Impact Research Focus – Dr. LV Qianghua’s work on anti-infection mechanisms and natural compound-based drug development aligns with global health priorities, particularly in combating superbacterial infections. His research on bacterial virulence factors like hemolysin, T3SS, and TFP contributes to the development of novel antimicrobial strategies.

  • Quality Publications in Reputable Journals – He has multiple first-author and co-first-author publications in high-impact journals, such as Journal of Cellular and Molecular Medicine and Applied Microbiology and Biotechnology. These papers focus on novel antibacterial mechanisms and natural product inhibitors, demonstrating both innovation and scientific rigor.

  • Translational Impact – His research not only advances basic microbiology but also holds significant translational potential in developing new antibacterial therapies, an area of urgent medical need due to rising antibiotic resistance.

  • Collaborative and Multi-Disciplinary Approach – His collaborations with researchers across multiple disciplines (pharmacology, microbiology, and veterinary medicine) enhance the applicability of his findings beyond veterinary science, benefiting both animal and human health.

  • Contribution to Veterinary Medicine – As an Associate Researcher at the IASVM, SAAS, Dr. LV contributes significantly to veterinary pharmacology, a field essential for both agricultural and public health. His work has implications for livestock disease management and food safety, making it highly relevant for both academia and industry.

🎓 Education

  • Ph.D. in Veterinary Pharmacology, Jilin University, 2020
    • Advisor: Prof. DENG Xuming
    • Research Focus: Anti-infection mechanisms of natural compounds targeting bacterial virulence factors

💼 Experience

  • Associate Researcher, IASVM, SAAS (2020–Present)
    • Conducting research on antibacterial strategies targeting virulence factors
    • Screening natural compounds for inhibitory effects on bacterial infections
    • Developing new therapeutic agents against superbacterial infections

🔬 Research Interests On Medicine

  • 🦠 Discovery and screening of novel targets and lead compounds against superb acterial infections
  • 💊 Synergistic antibacterial effects and mechanisms of natural compounds and antimicrobial agents

📚 Selected Publications

  • Title: Inhibition of the type III secretion system by syringaldehyde protects mice from Salmonella enterica serovar Typhimurium
    Authors: Lv Q(#), Chu X(#), Yao X, Ma K, Zhang Y*, Deng X*
    Publication Year: 2019
    Journal: Journal of Cellular and Molecular Medicine

  • Title: Identification of the natural product paeonol derived from peony bark as an inhibitor of the Salmonella enterica serovar Typhimurium type III secretion system
    Authors: Lv Q(#), Li S(#), Wei H, Wen Z, Wang Y, Tang T, Wang J, Xia L*, Deng X*
    Publication Year: 2020
    Journal: Applied Microbiology and Biotechnology

  • Title: Phloretin potentiates polymyxin E activity against Gram-negative bacteria
    Authors: Du R(#), Lv Q(#), Hu W, Hou X, Zhou Y, Deng X, Sun L, Li L, Deng Y, Wang J
    Publication Year: 2021
    Journal: Life Sciences

  • Title: Commercialized artemisinin derivatives combined with colistin protect against critical Gram-negative bacterial infection
    Authors: Zhou Y, Liu B, Chu X, Su J, Xu L, Li L, Deng X, Li D*, Lv Q*, Wang J*
    Publication Year: 2022
    Journal: Communications Biology

  • Title: Isoflavone glucoside genistin, an inhibitor targeting Sortase A and Listeriolysin O, attenuates the virulence of Listeria monocytogenes in vivo and in vitro
    Authors: Liu M(#), Lv Q(#), Xu J, Liu B, Zhou Y, Zhang S, Shen X, Wang L
    Publication Year: 2023
    Journal: Biochemical Pharmacology

🔚 Conclusion

Dr. LV Qianghua has dedicated his research to developing innovative antibacterial strategies, focusing on targeting bacterial virulence factors. His contributions in natural compound screening and new drug development have advanced the fight against superbacterial infections. With numerous impactful publications and ongoing research, he continues to make significant strides in veterinary medicine and pharmacology.

Massimo Petruzzi | Health Sciences | Excellence Award (Any Scientific field)

Published on by Forensic Scientist

Prof. Massimo Petruzzi | Health Sciences | Excellence Award (Any Scientific field)

Associate Professor | University of bari | Italy

Prof. Massimo Petruzzi is a distinguished Italian scholar in the field of oral medicine and stomatology. With a career spanning over two decades, he has made significant contributions to academic, clinical, and research domains. Currently serving as an Associate Professor at the University of Bari, his expertise in dentistry, oral pathology, and surgical interventions has earned him national and international recognition. Prof. Petruzzi is also a lecturer at the University of Bern, sharing his knowledge with the global academic community.

Profile

Strenghts for the Awards

  • Educational Achievements:
    • Completed scientific high school education with the highest honors (60/60).
    • Achieved a degree in Dentistry and Prosthetics with 110/110 and laude, accompanied by special commendations from the evaluation committee.
    • Completed a Ph.D. in Orto-Fonato-Rino-Stomatognatodonzia with substantial expertise in dental and oral sciences.
  • Professional Experience and Contributions:
    • Active researcher since 2005, consistently advancing in the academic field to become a full professor.
    • Extensive teaching portfolio spanning undergraduate, postgraduate, and doctoral programs, including mentoring doctoral students in oral pathology and medicine.
    • Engaged in interdisciplinary teaching and research collaborations at prestigious institutions like the University of Bern, Switzerland.
  • Specialization and Recognition:
    • Specialization in Chirurgia Odontostomatologica (Oral and Dental Surgery), securing top grades and recognition.
    • Winner of competitive research grants and academic positions in Italy, demonstrating his excellence in research and academia.
  • Publications and Research Contributions:
    • Prolific academic output with substantial contributions to research in Malattie Odontostomatologiche (Odontostomatological Diseases).
    • Expertise in clinical oral surgery and pathology, with significant impact on advancing dental practices.
  • Interdisciplinary Roles:
    • Served as an expert consultant for the Court of Taranto and military institutions, showcasing his ability to apply his research and expertise beyond academia.
    • Delivered numerous lectures and seminars, promoting oral health education and evidence-based dentistry practices.

Education 🎓

Prof. Petruzzi’s academic journey is marked by excellence. He graduated with a scientific diploma (Maturità Scientifica) in 1993, followed by a degree in Dentistry and Prosthodontics in 1999 from the University of Bari, where he achieved top honors (110/110 cum laude). In 2000, he specialized in Oral Medicine and Pathology and completed his Ph.D. in Orto-Fonato-Rino-Stomatognathodontics in 2004. His rigorous academic foundation was further bolstered by a specialization in Oral Surgery in 2012, where he again achieved top grades.

Experience 🏢

Prof. Petruzzi began his career as a university researcher in 2005 and achieved tenure in 2008. Since 2015, he has held the position of Associate Professor in Oral and Stomatological Diseases at the University of Bari. His teaching responsibilities span undergraduate, postgraduate, and doctoral levels, and he has been actively involved in developing interdisciplinary courses. His military service as a Dental Officer in the Italian Navy from 2000 to 2001 highlights his versatility and commitment to service.

🔬Research Interests  On Health Sciences

Prof. Petruzzi’s research primarily focuses on oral medicine, pathology, and stomatological diseases. He has contributed extensively to the understanding and treatment of oral mucosal diseases, laser dentistry, and minimally invasive surgical techniques. His work is characterized by a strong emphasis on translational research, aiming to bridge the gap between scientific discoveries and clinical applications.

Awards and Recognitions 🏆

Throughout his career, Prof. Petruzzi has received numerous awards, including competitive scholarships for his Ph.D. program and distinctions for academic excellence. His habilitation for the role of Full Professor in Oral Diseases (2017–2028) is a testament to his professional achievements and expertise in the field. Additionally, he has been recognized for his contributions to scientific research and education at both national and international levels.

Final Note 📘

Prof. Massimo Petruzzi exemplifies academic and professional excellence in oral medicine and dentistry. His contributions to research, teaching, and clinical practice have significantly advanced the field, benefiting both students and patients. Prof. Petruzzi continues to inspire the next generation of dental professionals with his dedication to innovation and education.

Publications 📚🖋️

1. Hepatitis C Virus (HCV) Infection: Pathogenesis, Oral Manifestations, and the Role of Direct-Acting Antiviral Therapy: A Narrative Review

  • Authors: Di Stasio, D.; Guida, A.; Romano, A.; Fiori, F.; Lucchese, A.
  • Publication Year: 2024
  • Citations: 1

2. Oral Manifestations in Paraneoplastic Syndromes: A Systematic Review and Meta-Analysis

  • Authors: Messina, S.; De Falco, D.; Petruzzi, M.
  • Publication Year: 2024
  • Citations: 0

3. Proposal of a Modified Technique of Nikolsky’s Sign in Oral Autoimmune Vesiculobullous Diseases

  • Authors: Petruzzi, M.
  • Publication Year: 2024
  • Citations: 0

4. Diagnostic Delay in Autoimmune Oral Diseases

  • Authors: Petruzzi, M.; Della Vella, F.; Squicciarini, N.; Lucchese, A.; van der Waal, I.
  • Publication Year: 2023
  • Citations: 10

5. Blood Clotting Dissolution in the Presence of a Magnetic Field and Preliminary Study with MG63 Osteoblast-like Cells—Further Developments for Guided Bone Regeneration?

  • Authors: Di Gioia, S.; Milillo, L.; Hossain, M. N.; Petruzzi, M.; Conese, M.
  • Publication Year: 2023
  • Citations: 0

6. Exploring the Association of Burning Mouth Syndrome with Depressive and Anxiety Disorders in Middle-Aged and Older Adults: A Systematic Review

  • Authors: Dibello, V.; Ballini, A.; Lozupone, M.; Solfrizzi, V.; Panza, F.
  • Publication Year: 2023
  • Citations: 4

7. Oral Candidiasis and Novel Therapeutic Strategies: Antifungals, Phytotherapy, Probiotics, and Photodynamic Therapy

  • Authors: Contaldo, M.; Di Stasio, D.; Romano, A.; Serpico, R.; Lucchese, A.
  • Publication Year: 2023
  • Citations: 22

8. Oral Frailty Indicators to Target Major Adverse Health-Related Outcomes in Older Age: A Systematic Review

  • Authors: Dibello, V.; Lobbezoo, F.; Lozupone, M.; Manfredini, D.; Panza, F.
  • Publication Year: 2023
  • Citations: 50

9. Guided Bone Regeneration with Occlusive Titanium Barrier: A Case Report and Clinical Considerations

  • Authors: Milillo, L.; Petruzzi, M.
  • Publication Year: 2023
  • Citations: 1